No abstract available
Publication types
-
Case Reports
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Aged
-
Alanine Transaminase / blood
-
Alkaline Phosphatase / blood
-
Antineoplastic Agents / adverse effects*
-
Aspartate Aminotransferases / blood
-
Benzamides
-
Bilirubin / blood
-
Blood Cell Count
-
Erythrocyte Indices
-
Humans
-
Imatinib Mesylate
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy
-
Liver Failure / blood
-
Liver Failure / chemically induced*
-
Liver Failure / pathology
-
Male
-
Necrosis
-
Piperazines / adverse effects*
-
Protein Kinase Inhibitors / adverse effects*
-
Prothrombin Time
-
Pyrimidines / adverse effects*
-
Time Factors
Substances
-
Antineoplastic Agents
-
Benzamides
-
Piperazines
-
Protein Kinase Inhibitors
-
Pyrimidines
-
Imatinib Mesylate
-
Aspartate Aminotransferases
-
Alanine Transaminase
-
Alkaline Phosphatase
-
Bilirubin